Alles Mark J

Director at Turning Point Therapeutics, Inc. · on record since May 26, 2021
Director at CELGENE CORP /DE/ · on record since May 3, 2016
CEO, CHAIRMAN OF BOARD at CELGENE CORP /DE/ · on record since May 17, 2018
Director at Syros Pharmaceuticals, Inc. · on record since Dec 20, 2019
Director at BIOMARIN PHARMACEUTICAL INC · on record since Jan 5, 2022

Insider trading activity of Alles Mark J

Transactions on record: 301; since Mar 7, 2012

Open-market buys: 5; $965.1K

Open-market sells: 3; $29M

Companies traded: 4; last filing Sep 19, 2023

Figures computed from official regulatory filings — .

Companies where Alles Mark J has traded

Syros Pharmaceuticals, Inc.11 tx · $88.6K · Sep 19, 2023
BIOMARIN PHARMACEUTICAL INC4 tx · $314.5K · May 24, 2023
Turning Point Therapeutics, Inc.6 tx · $314.7K · Aug 17, 2022
CELGENE CORP /DE/280 tx · $53.8M · Nov 22, 2019

Track record of Alles Mark J

Statistical track record

Free account

Open-market buys: 5

Last buy: Oct 31, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Alles Mark J

Co-insiders of Alles Mark J

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2023	ExerciseD (derivative)	-2,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2023	Exercise	2,666	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 2, 2023	AwardD (derivative)	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 2, 2023	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 24, 2023	Award	4,190	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Nov 2, 2022	Buy	3,625	86.75 USD	$314.5K	conv 51First in 12mo	SEC
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2022	AwardD (derivative)	8,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2022	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	Aug 17, 2022	OtherD (derivative)	-209	—	n/a (No price was disclosed in the filing)		SEC
Turning Point Therapeutics, Inc.Listing unverified	Aug 17, 2022	OtherD (derivative)	-17,000	—	n/a (No price was disclosed in the filing)		SEC
Turning Point Therapeutics, Inc.Listing unverified	Aug 17, 2022	Other	-2,000	76.00 USD	$152K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 2, 2022	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 26, 2022	Award	4,980	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 5, 2022	Award	2,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	Jun 21, 2021	Buy	2,000	81.34 USD	$162.7K	conv 29First in 12mo	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 10, 2021	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	Jun 4, 2021	AwardD (derivative)	209	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	May 26, 2021	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 11, 2020	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	May 13, 2020	Buy	10,000	8.86 USD	$88.6K	conv 47First in 12mo	SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 20, 2019	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	Other	-366,495	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	OtherD (derivative)	-33,881	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	OtherD (derivative)	-17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	OtherD (derivative)	-115,755	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2023	ExerciseD (derivative)	-2,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2023	Exercise	2,666	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 2, 2023	AwardD (derivative)	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 2, 2023	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 24, 2023	Award	4,190	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Nov 2, 2022	Buy	3,625	86.75 USD	$314.5K	conv 51First in 12mo	SEC
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2022	AwardD (derivative)	8,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Sep 19, 2022	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	Aug 17, 2022	OtherD (derivative)	-209	—	n/a (No price was disclosed in the filing)		SEC
Turning Point Therapeutics, Inc.Listing unverified	Aug 17, 2022	OtherD (derivative)	-17,000	—	n/a (No price was disclosed in the filing)		SEC
Turning Point Therapeutics, Inc.Listing unverified	Aug 17, 2022	Other	-2,000	76.00 USD	$152K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 2, 2022	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 26, 2022	Award	4,980	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 5, 2022	Award	2,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	Jun 21, 2021	Buy	2,000	81.34 USD	$162.7K	conv 29First in 12mo	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 10, 2021	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	Jun 4, 2021	AwardD (derivative)	209	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turning Point Therapeutics, Inc.Listing unverified	May 26, 2021	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 11, 2020	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	May 13, 2020	Buy	10,000	8.86 USD	$88.6K	conv 47First in 12mo	SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 20, 2019	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	Other	-366,495	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	OtherD (derivative)	-33,881	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	OtherD (derivative)	-17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CELGENE CORP /DE/Listing unverified	Nov 22, 2019	OtherD (derivative)	-115,755	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC